1. Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis
   Iris Pujade et al, 2020, Pharmacological Research CrossRef
2. Therapeutic experience of ticagrelor in Indian patients with acute coronary syndrome: A non-interventional, prospective, and observational study
   J.P.S. Sawhney et al, 2019, Indian Heart Journal CrossRef
3. Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct PCI
   Hui Li et al, 2018, Experimental and Therapeutic Medicine CrossRef
4. Ticagrelor versus clopidogrel in East Asian patients with acute coronary syndrome: A meta-analysis
   Meijiao He et al, 2022, Frigid Zone Medicine CrossRef
5. Comparison of Ticagrelor With Clopidogrel in East Asian Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
   Ying Ma et al, 2022, Journal of Cardiovascular Pharmacology CrossRef
6. The risk of dyspnea in patients treated with third-generation P2Y12 inhibitors compared with clopidogrel: a meta-analysis of randomized controlled trials
   Na Zhang et al, 2020, BMC Cardiovascular Disorders CrossRef
7. Inhibitory effect of resveratrol on the pharmacokinetics of ticagrelor in vivo and in vitro
   Peng Wang et al, 2021, Canadian Journal of Physiology and Pharmacology CrossRef
8. Efficacy and Safety of Clopidogrel Versus Ticagrelor as Part of Dual Antiplatelet Therapy in Acute Coronary Syndrome—A Systematic Review and Meta-analysis
   Niklas Bergh et al, 2022, Journal of Cardiovascular Pharmacology CrossRef